No | Age (years) | Sex | Aetiology | Period to shunt (d) | NAA/Cr | NAA/Cho | Cho/Cr | mIns/Cr | Preoperative evaluation | Postoperative evaluation (1 month) | Postoperative evaluation (1 year) | Clinical evaluation | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HDS-R | Gait score | Incont | m-Rankin | HDS-R | Gait score | Incont | m-Rankin | HDS-R | Gait score | Incont | m-Rankin | 1 month | 12 months | |||||||||
*Intraventricular haemorrhage of unknown origin. | ||||||||||||||||||||||
†Right acoustic schwannoma, volume ∼1 cm3. | ||||||||||||||||||||||
‡Patient 2 was lost to follow up at 12 months. | ||||||||||||||||||||||
Cho, choline compounds; Cr, creatine; F, female; HDS-R, Hasegawa’s dementia scale; incont, incontinence; M, male; mIns, myoinositol; m-Rankin, modified Rankin scale; NAA, N-acetylaspartate; SAH, subarachnoid haemorrhage. | ||||||||||||||||||||||
1 | 58 | M | SAH | 16 | 1.00 | 0.93 | 1.08 | 0.46 | 00 | 1 | + | 5 | 00 | 2 | + | 4 | 02 | 2 | + | 4 | Poor | Poor |
2‡ | 75 | F | SAH | 59 | 1.59 | 1.45 | 1.10 | 0.19 | 00 | 1 | + | 5 | 23 | 3 | − | 4 | . | . | . | . | Excellent | – |
3 | 64 | M | SAH | 40 | 1.67 | 1.32 | 1.27 | 0.22 | 00 | 1 | + | 5 | 30 | 4 | − | 3 | 00 | 2 | + | 4 | Excellent | Poor |
4 | 57 | M | SAH | 64 | 1.72 | 1.84 | 0.93 | 0.28 | 10 | 4 | + | 3 | 22 | 5 | − | 2 | 29 | 4 | − | 3 | Excellent | Excellent |
5 | 62 | F | SAH | 24 | 1.46 | 1.36 | 1.07 | 0.40 | 04 | 1 | + | 5 | 30 | 5 | − | 2 | 27 | 5 | − | 1 | Excellent | Excellent |
6 | 53 | F | SAH | 46 | 1.35 | 1.64 | 0.83 | 0.27 | 05 | 1 | + | 5 | 26 | 5 | − | 2 | 27 | 4 | − | 1 | Excellent | Excellent |
7 | 38 | M | Haemorrhage* | 33 | 1.96 | 2.39 | 0.82 | 0.23 | 04 | 1 | − | 3 | 29 | 4 | − | 2 | 30 | 5 | − | 1 | Excellent | Excellent |
8 | 59 | F | SAH | 24 | 1.38 | 1.62 | 0.85 | 0.21 | 00 | 1 | + | 5 | 17 | 5 | − | 2 | 30 | 4 | − | 1 | Fair | Excellent |
9 | 77 | F | SAH | 75 | 1.06 | 1.19 | 0.89 | 0.40 | 02 | 1 | + | 5 | 01 | 1 | + | 5 | . | . | . | . | Poor | (Dead) |
10 | 48 | M | SAH | 45 | 1.83 | 1.90 | 0.96 | 0.29 | 04 | 4 | + | 3 | 28 | 5 | − | 2 | 30 | 5 | − | 1 | Excellent | Excellent |
11 | 75 | F | SAH | 68 | 1.25 | 1.03 | 1.22 | 0.45 | 00 | 1 | + | 5 | 07 | 3 | + | 4 | 05 | 4 | + | 3 | Fair | Fair |
12 | 61 | F | SAH | 50 | 1.24 | 1.15 | 1.08 | 0.29 | 00 | 1 | + | 5 | 00 | 1 | + | 5 | 00 | 1 | + | 4 | Poor | Poor |
13 | 57 | F | SAH | 56 | 1.28 | 1.26 | 1.01 | 0.44 | 12 | 1 | + | 4 | 14 | 1 | + | 4 | 00 | 1 | + | 5 | Poor | Poor |
14 | 54 | M | SAH | 67 | 1.51 | 1.27 | 1.19 | 0.16 | 13 | 4 | − | 3 | 23 | 5 | − | 2 | 30 | 5 | − | 2 | Excellent | Excellent |
15 | 50 | F | Meningitis | 11 | 1.68 | 1.35 | 1.25 | 0.18 | 14 | 4 | − | 3 | 29 | 5 | − | 2 | 24 | 5 | + | 2 | Excellent | Fair |
16 | 69 | F | Tumour‡ | 16 | 1.97 | 1.90 | 1.04 | 0.38 | 04 | 1 | + | 4 | 28 | 5 | − | 2 | 28 | 5 | − | 1 | Excellent | Excellent |
17 | 65 | M | Meningitis | 49 | 1.54 | 1.20 | 1.29 | 0.17 | 07 | 1 | + | 5 | 23 | 3 | − | 4 | 23 | 4 | + | 3 | Excellent | Fair |
18 | 62 | M | SAH | 76 | 1.16 | 0.91 | 1.27 | 0.24 | 00 | 1 | + | 5 | 08 | 2 | + | 4 | 11 | 3 | + | 4 | Poor | Fair |
19 | 74 | F | SAH | 42 | 1.72 | 1.35 | 1.27 | 0.18 | 00 | 1 | + | 5 | 25 | 4 | − | 3 | 26 | 5 | − | 0 | Excellent | Excellent |
20 | 60 | F | SAH | 42 | 1.95 | 1.53 | 1.27 | 0.20 | 00 | 1 | + | 4 | 29 | 3 | − | 3 | 25 | 5 | − | 0 | Excellent | Excellent |
21 | 74 | F | SAH | 56 | 1.40 | 1.19 | 1.17 | 0.20 | 00 | 1 | + | 4 | 24 | 1 | + | 4 | 27 | 2 | + | 4 | Fair | Fair |